Viewing nowCombinationEdis Tablet
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.

MFDS item code 201500191 · Approved 2015.01.14
This product's status changed to Expired on 2025.01.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (ulcers, gastritis, etc.); prevention of Mendelson's syndrome before anesthesia
This medication is used to treat gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps prevent ulcers after surgery and treats ulcers induced by NSAIDs (non-steroidal anti-inflammatory drugs). It is administered to prevent Mendelson's syndrome prior to anesthesia. This drug alleviates symptoms caused by excessive gastric acid and protects the gastric mucosa, assisting in patient recovery. Therefore, it is effectively used in the treatment of various gastrointestinal disorders.
○ Adults Usually, administer 2 tablets orally twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers Administer 2 tablets twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets twice daily, in the morning and at bedtime. The dose is the same when used in combination to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug administration usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets twice daily for 8 weeks or 4 tablets once daily at bedtime. The dose may be increased to 4 tablets 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets 3 times daily and increase the dose if needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets on the night before surgery.
This medication should not be administered to patients undergoing dialysis or those with diminished kidney function. Additionally, it should not be given to patients with a history of allergic reactions to this drug or its components, patients with acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, and neonates, as well as patients on restricted potassium intake diets. Patients with liver function issues, a history of drug allergies, elderly patients, and patients with a history of kidney dysfunction should exercise particular caution when using this medication. If used in conjunction with non-steroidal anti-inflammatory drugs, especially in elderly patients or those with a history of peptic ulcers, regular monitoring is required. This drug can mask symptoms of gastric cancer, so it should be administered to patients with gastric ulcers or those in middle age or older who have newly appeared dyspeptic symptoms only after malignancy has been ruled out. Patients with Helicobacter pylori positive gastric or duodenal ulcers should undergo concurrent eradication therapy. Special attention should be taken in critically ill patients due to the risk of gastric stone formation, and in patients with hypophosphatemia or those with swallowing difficulties when taking this medication. Rarely, serious allergic reactions or various adverse reactions involving the blood, liver, heart, digestive system, and nervous system can occur, so symptoms should be reported to medical personnel immediately. Long-term use should be avoided, and careful monitoring of the treatment course is important while administering the minimum effective dose. Elderly patients or those with chronic lung disease, diabetes, and weakened immune systems may be at increased risk of pneumonia, and caution is required. Patients experiencing dizziness or drowsiness while taking this medication should avoid driving or operating dangerous machinery. This medication can interact with other drugs, so individuals taking any other medications should inform their healthcare provider, as some drugs may require dosage adjustments when taken concurrently. Pregnant or nursing women are advised not to use this medication, and its safety and efficacy in children have not been established; therefore, its use is not recommended. During clinical tests, this medication may affect test results, so it is advisable to inform medical personnel about its intake before tests. In cases of overdose, appropriate treatment such as vomiting or gastric lavage is needed, and in severe cases, blood dialysis may be required. Lastly, this medication reduces gastric acid secretion, which may promote bacterial growth in the gastrointestinal tract; thus, eye examinations may be necessary with long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is best to maintain a storage temperature between 1 and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Eden Pharma Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.